Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by Analystguyon Dec 08, 2018 10:25am
325 Views
Post# 29086743

Financial backers reducing ACB holdings. Should we worry?

Financial backers reducing ACB holdings. Should we worry?
Looking at the AGM video, emphasis is given only to revenue growth during this past year. Not a peep about expense or eps. Without knowing the expense side, investors aren't getting the real picture of the company's performance. It should go without saying that revenue increases with more acquisitions.

We are now almost midway through the final month of the quarter and ACB should now have a pretty good picture of how the finances for the quarter will end. I say this because I've done this for many years for multi billion dollar multi national publicly listed companies.

What troubles me is that as of yesterday Dec 7th - both Cannacord Genuity, the underwriter of ACB's $200 million bought deal issued Jan 5, 2018, and BMO Nesbitt Burns the issuer of ACB's $250 million credit facility, have decreased their share holdings in ACB relative to Nov 2nd to zero. Why would they do this unless they knew something we didn't?


User image
Bullboard Posts